Market Cap 3.32M
Revenue (ttm) 4.91M
Net Income (ttm) -53.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,080.24%
Debt to Equity Ratio 0.06
Volume 4,396,400
Avg Vol 1,630,932
Day's Range N/A - N/A
Shares Out 42.23M
Stochastic %K 30%
Beta 2.39
Analysts Hold
Price Target $1.50

Company Profile

Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. It also develops Tildacerfont for treating a highly debilitating mental disorder characterized by depressed mood with cognitive-affective and somatic changes, includ...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 655 4168
Address:
611 Gateway Boulevard, Suite 740, South San Francisco, United States
mrtmermer80
mrtmermer80 Aug. 22 at 8:53 PM
$SPRB 8 more trading days left!
0 · Reply
mrtmermer80
mrtmermer80 Aug. 22 at 2:25 PM
$SPRB Why someone sell their shares now, right before getting listed on NASADAQ again. there is no actual selling pressure at all. Someone is goofing around. It is holding good when you consider you can not buy this stock on most of the brokerages.
0 · Reply
alien7180
alien7180 Aug. 22 at 1:55 PM
$SPRB I’m in
0 · Reply
LQQKER_INSIDER
LQQKER_INSIDER Aug. 21 at 1:24 AM
$SPRB This company is so OVER CONFIDENT in their prospects, that they won't even respond to investors emails. And so OVER CONFIDENT in their "new" drug, that they weren't even spooked off by the fact that (of all the peeps in the WORLD previously taking the drug from earlier trials) a grand total of T-W-O sought compassionate care in order to stay on the drug after the previous owners of the drug went BANKRUPT! Management's TRUE objective was likely just staying employed, as no one else would have likely hired them.
0 · Reply
WilliamAnastasiades488
WilliamAnastasiades488 Aug. 18 at 2:46 PM
$SPRB investors know the field is crowded. KLTO’s focus on safer tissue-specific delivery may help it stand out.
0 · Reply
mrtmermer80
mrtmermer80 Aug. 15 at 8:01 PM
$SPRB There is gonna be a day we will have over 1m volume.
1 · Reply
mrtmermer80
mrtmermer80 Aug. 15 at 3:18 PM
$SPRB Put all other products aside, if TA-ERT is successful only, this company is worth $200M right away. Current MC is $5M. Lets say that they will have a dilution(1/2) on the road. If someone buys now $5M MC, can have 20x in return in a year(calculating the dilution as well).
0 · Reply
joe77w
joe77w Aug. 15 at 12:04 PM
$SPRB https://www.biospace.com/press-releases/spruce-biosciences-announces-integrated-long-term-clinical-data-of-tralesinidase-alfa-enzyme-replacement-therapy-ta-ert-demonstrating-profound-and-durable-efficacy-and-safety-in-patients-with-sanfilippo-syndrome-type-b-mps-iiib
1 · Reply
joe77w
joe77w Aug. 15 at 11:41 AM
$SPRB excellent news about TA ERT, It Is simply Crazy market does not understand the huge therapy for Sanfilippo disease. This co could be worth hundreds and hundreds of millions when and if TA ERT approved next year. Market cap only 5 mln USD while cash alone 20 mln and Rich pipeline between assets Once relisted in early September I firmly believe thing Will change. Management did an excellent job adding 3 compounds with significant value. Do your dd before investing, this Is not a financial advice, read last 10Q Just issued
0 · Reply
Stmkr
Stmkr Aug. 15 at 2:15 AM
$SPRB runway to the end of 2025
0 · Reply
Latest News on SPRB
No data available.
mrtmermer80
mrtmermer80 Aug. 22 at 8:53 PM
$SPRB 8 more trading days left!
0 · Reply
mrtmermer80
mrtmermer80 Aug. 22 at 2:25 PM
$SPRB Why someone sell their shares now, right before getting listed on NASADAQ again. there is no actual selling pressure at all. Someone is goofing around. It is holding good when you consider you can not buy this stock on most of the brokerages.
0 · Reply
alien7180
alien7180 Aug. 22 at 1:55 PM
$SPRB I’m in
0 · Reply
LQQKER_INSIDER
LQQKER_INSIDER Aug. 21 at 1:24 AM
$SPRB This company is so OVER CONFIDENT in their prospects, that they won't even respond to investors emails. And so OVER CONFIDENT in their "new" drug, that they weren't even spooked off by the fact that (of all the peeps in the WORLD previously taking the drug from earlier trials) a grand total of T-W-O sought compassionate care in order to stay on the drug after the previous owners of the drug went BANKRUPT! Management's TRUE objective was likely just staying employed, as no one else would have likely hired them.
0 · Reply
WilliamAnastasiades488
WilliamAnastasiades488 Aug. 18 at 2:46 PM
$SPRB investors know the field is crowded. KLTO’s focus on safer tissue-specific delivery may help it stand out.
0 · Reply
mrtmermer80
mrtmermer80 Aug. 15 at 8:01 PM
$SPRB There is gonna be a day we will have over 1m volume.
1 · Reply
mrtmermer80
mrtmermer80 Aug. 15 at 3:18 PM
$SPRB Put all other products aside, if TA-ERT is successful only, this company is worth $200M right away. Current MC is $5M. Lets say that they will have a dilution(1/2) on the road. If someone buys now $5M MC, can have 20x in return in a year(calculating the dilution as well).
0 · Reply
joe77w
joe77w Aug. 15 at 12:04 PM
$SPRB https://www.biospace.com/press-releases/spruce-biosciences-announces-integrated-long-term-clinical-data-of-tralesinidase-alfa-enzyme-replacement-therapy-ta-ert-demonstrating-profound-and-durable-efficacy-and-safety-in-patients-with-sanfilippo-syndrome-type-b-mps-iiib
1 · Reply
joe77w
joe77w Aug. 15 at 11:41 AM
$SPRB excellent news about TA ERT, It Is simply Crazy market does not understand the huge therapy for Sanfilippo disease. This co could be worth hundreds and hundreds of millions when and if TA ERT approved next year. Market cap only 5 mln USD while cash alone 20 mln and Rich pipeline between assets Once relisted in early September I firmly believe thing Will change. Management did an excellent job adding 3 compounds with significant value. Do your dd before investing, this Is not a financial advice, read last 10Q Just issued
0 · Reply
Stmkr
Stmkr Aug. 15 at 2:15 AM
$SPRB runway to the end of 2025
0 · Reply
mrtmermer80
mrtmermer80 Aug. 13 at 12:42 PM
$SPRB Looks like lots of Funds end up selling their shares when SPRB listed on OTC market. My question is who ended up collecting all these shares that they sold. Definitely not bought by all retail. We will see soon.
0 · Reply
keokeostwiz
keokeostwiz Aug. 12 at 6:22 PM
$SPRB Going nowhere until relisted on NASDAQ and financing details released
1 · Reply
joe77w
joe77w Aug. 11 at 2:04 PM
$SPRB 40/50 USD with Sanfilippo drug positive update imo
0 · Reply
worldslargestpenguin
worldslargestpenguin Aug. 9 at 4:09 PM
$SPRB this is a hidden gem opportunity PRV alone is worth $150M
1 · Reply
mrtmermer80
mrtmermer80 Aug. 8 at 5:11 PM
$SPRB OTC market sucks!
1 · Reply
joe77w
joe77w Aug. 7 at 4:16 PM
$SPRB there Is literally no float and manu brokers dont let traders or investors or speculative traders buy stock on OTC. Once relisted we Will have update about Sanfilippo drug and if positive stock Will go to the Moon imo, I Will like huge funding with partnership
0 · Reply
mrtmermer80
mrtmermer80 Aug. 7 at 2:35 PM
$SPRB This needs to be re-listed on NASDAQ again. Looks like it will be relisted on NASDAQ on September 5th. Since then, I do not expect anything big, not sure how OTC markets works for RS stocks. Normally, this ticker should have got high alert after RS with huge volume.
0 · Reply
joe77w
joe77w Aug. 7 at 11:23 AM
$SPRB RS EFFECTIVE NEW TICKER SPRBD for next 20 trading days then NASDAQ again Only way up imo, huge bounce player 🤑
0 · Reply
joe77w
joe77w Aug. 6 at 7:45 PM
$SPRB keep calma, RS still not happened May be for technical reasons. Co does own a great Pipeline and an almost approved rare disease drug in 2026, a cash position 3/4X current market cap
0 · Reply
Monsters_of_Swing
Monsters_of_Swing Aug. 6 at 6:58 PM
$SPRB zero communication a joke company
0 · Reply
mrtmermer80
mrtmermer80 Aug. 6 at 6:30 PM
$SPRB Something is up. Either bas or good. Not sure. Ask at 0.135 bids at .105. Big gap
0 · Reply
keokeostwiz
keokeostwiz Aug. 6 at 5:09 PM
$SPRB Curious regarding cancel info R/S.......wanting a PR from company......tell us what is going on.....HMNC to the rescue????.....inquiring minds want to know
0 · Reply